Table 2 Characteristics of confirmed persons with epilepsy
Umuezeala | Umuoparaodu | Overall | ||
|---|---|---|---|---|
Number of confirmed PWE | 3 | 1 | 4 | |
Prevalence of epilepsy | 0.6% | 0.3% | 0.5% | |
Age of confirmed PWE in 2018: Median (IQR) | 18 (16–45) | 18 | 18 (16.5–38.3) | |
Age at onset of epilepsy: Median (IQR) | 7 (6–30) | 15 | 11 (6.3–26.3) | |
Duration of epilepsy in years | 12 (9–15) | 3 | 10.5 (4.5–14.3) | |
Seizure type | Generalized tonic clonic | 3 (100%) | 1 (100%) | 4 (100%) |
Absences | 1 (33.3%) | 1 (100%) | 2 (50%) | |
Focal | 0 | 0 | 0 | |
Nodding | 0 | 0 | 0 | |
Seizure frequency | Daily: > 30/month | 0 | 0 | 0 |
Monthly: > 12/year | 3 (100%) | 1 (100%) | 4 (100%) | |
Yearly: < 12/year | 0 | 0 | 0 | |
Burns / wounds | 0 | 0 | 0 | |
Past medical history | Birth dystocia | 0 | 0 | 0 |
Cerebral Malaria | 0 | 0 | 0 | |
Measles | 0 | 0 | 0 | |
Head trauma | 0 | 0 | 0 | |
Probable eclampsia | 1 (33.3%) | 0 | 1 (25%) | |
Immigrants | 2 (66.7%) | 1 (100%) | 3 (75%) | |
Clinical signs of onchocerciasis | Leopard skin | 0 | 0 | 0 |
Nodules | 0 | 0 | 0 | |
Seizure treatment | Antiepileptic drugs | 3 (100%) | 0 | 3 (75%) |
Traditional medicine | 0 | 1 (100%) | 1 (25%) | |
Ivermectin use prior to seizure onset | 1 (33.3%) | 0 | 1 (25%) | |
Positive Ov16 test | 0 | 0 | 0 | |
Positive skin snip | 0 | 0 | 0 | |